The main reasons for finite Nuc therapy in HBeAg-negative chronic hepatitis B patients

Chien Wei Peng; Wen Juei Jeng

doi:10.1007/s12072-021-10168-9

The main reasons for finite Nuc therapy in HBeAg-negative chronic hepatitis B patients

Chien Wei Peng, Wen Juei Jeng^*

^*Corresponding author for this work

School of Medicine

Research output: Contribution to journal › Journal Letter › peer-review

Original language	English
Pages (from-to)	527-528
Number of pages	2
Journal	Hepatology International
Volume	15
Issue number	2
DOIs	https://doi.org/10.1007/s12072-021-10168-9
State	Published - 04 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s12072-021-10168-9

Cite this

@article{b352bc0c35bc49aca84f6c1a8f9c8468,

title = "The main reasons for finite Nuc therapy in HBeAg-negative chronic hepatitis B patients",

author = "Peng, {Chien Wei} and Jeng, {Wen Juei}",

year = "2021",

month = apr,

doi = "10.1007/s12072-021-10168-9",

language = "英语",

volume = "15",

pages = "527--528",

journal = "Hepatology International",

issn = "1936-0533",

publisher = "Springer",

number = "2",

}

TY - JOUR

T1 - The main reasons for finite Nuc therapy in HBeAg-negative chronic hepatitis B patients

AU - Peng, Chien Wei

AU - Jeng, Wen Juei

PY - 2021/4

Y1 - 2021/4

UR - http://www.scopus.com/inward/record.url?scp=85104825242&partnerID=8YFLogxK

U2 - 10.1007/s12072-021-10168-9

DO - 10.1007/s12072-021-10168-9

M3 - 快报

C2 - 33904110

AN - SCOPUS:85104825242

SN - 1936-0533

VL - 15

SP - 527

EP - 528

JO - Hepatology International

JF - Hepatology International

IS - 2

ER -

The main reasons for finite Nuc therapy in HBeAg-negative chronic hepatitis B patients

UN SDGs

Access to Document

Other files and links

Cite this